Insights

Gathering insights about Atrium…

Similar companies to Atrium

Atrium Tech Stack

Atrium uses 6 technology products and services including Google Workspace, Google Cloud, Lua, and more. Explore Atrium's tech stack below.

Google Workspace
Email
Google Cloud
Infrastructure As A Service
Lua
Programming Languages
GoDaddy
Web Hosting
OpenResty
Web Servers
Nginx
Web Servers

Media & News

Avidity Biosciences (NASDAQ:RNA) Sets New 52-Week Low – Here’s Why
Avidity Biosciences, Inc. (NASDAQ: RNA - Get Free Report) shares hit a new 52-week low on Saturday. The company traded as low as $13.06 and last traded at $14.75, with a volume of 7932167 shares changing hands. The stock had previously closed at $14.58. Analyst Ratings Changes A number of analysts have commented on RNA
Mar 02, 2026 | www.defenseworld.net
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
Spinoff from Novartis AG's acquisition of Avidity Biosciences advances precision cardiology programs using targeted RNA delivery platform Lead candidates ATR 1072 and ATR 1086 expected to enter clinical trials for PRKAG2 syndrome and PLN cardiomyopathy, respectively SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Atrium Therapeutics, Inc. (Nasdaq: RNA) launched today as a newly independent, publicly traded company dedicated to delivering RNA therapeutics directly to the heart to transform care for people living with rare, life-threatening genetic cardiomyopathies. Atrium Therapeutics was established in connection with Avidity Biosciences, Inc.'s acquisition by Novartis AG.
Feb 27, 2026 | www.prnewswire.com
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
SAN DIEGO, Feb. 26, 2026 /PRNewswire/ -- Avidity Biosciences, Inc. ("Avidity") (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™) to profoundly improve people's lives, today announced that the company will be presenting one oral and six poster presentations at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, being held March 8-11, 2026, in Orlando, Florida. 2026 MDA Clinical & Scientific Congress Presentations Oral Presentation: Del-zota Treatment is Associated with Near Normalization of CK Levels and Improvements in Key Functional Outcomes at 1 Year in Participants with DMD44 (March 11, 2026: 12:30 p.m.
Feb 26, 2026 | www.prnewswire.com
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
SAN DIEGO, Feb. 23, 2026 /PRNewswire/ -- Avidity Biosciences, Inc. ("Avidity") (NASDAQ: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates ("AOCs™") to profoundly improve people's lives, today announced that it intends to convene its upcoming special meeting of stockholders (the "Special Meeting") scheduled for February 23, 2026, at 10:00 a.m., Eastern time, and then immediately adjourn proceedings, without conducting any other business.
Feb 23, 2026 | www.prnewswire.com
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
Del-desiran effectively delivered siRNA to muscle, resulting in approximately 40% mean reduction in DMPK mRNA and amelioration of missplicing Treatment demonstrated improvements in multiple measures including myotonia, muscle function and strength, mobility and patient-reported outcomes Del-desiran showed acceptable safety and tolerability with most adverse events mild or moderate SAN DIEGO, Feb. 18, 2026 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that the final results from the completed Phase 1/2 MARINA® trial of delpacibart etedesiran (del-desiran) in people living with myotonic dystrophy type 1 (DM1) will be published in the February 19 issue of The New England Journal of Medicine (NEJM). The manuscript is titled "An Antibody Oligonucleotide Conjugate for Myotonic Dystrophy Type 1.
Feb 18, 2026 | www.prnewswire.com

Atrium's Email Address Formats

Atrium uses at least 1 format(s):

Atrium Email Formats	Example	Percentage
First@atriumnyc.com	John@atriumnyc.com	60%
Last@atriumnyc.com	Doe@atriumnyc.com	40%

Frequently Asked Questions

Where is Atrium's headquarters located?

Atrium's main headquarters is located at 644 Broadway New York, New York 10012 United States. The company has employees across 4 continents, including North AmericaAsiaAfrica.

What is Atrium's stock symbol?

Atrium is a publicly traded company; the company's stock symbol is RNA.

What is Atrium's official website and social media links?

Atrium's official website is atriumnyc.com and has social profiles on LinkedIn.

How much revenue does Atrium generate?

As of March 2026, Atrium's annual revenue is estimated to be $9M.

What is Atrium's SIC code NAICS code?

Atrium's SIC code is 5932 - Used Merchandise Stores NAICS code is 448 - Clothing and Clothing Accessories Stores.

How many employees does Atrium have currently?

As of March 2026, Atrium has approximately 49 employees across 4 continents, including North AmericaAsiaAfrica. Key team members include Co-Founder: S. A.Co-Founder: S. B.General Manager Product Support: S. B.. Explore Atrium's employee directory with LeadIQ.

What industry does Atrium belong to?

Atrium operates in the Retail Apparel and Fashion industry.

What technology does Atrium use?

Atrium's tech stack includes Google WorkspaceGoogle CloudLuaGoDaddyOpenRestyNginx.

What is Atrium's email format?

Atrium's email format typically follows the pattern of First@atriumnyc.com. Find more Atrium email formats with LeadIQ.

When was Atrium founded?

Atrium was founded in 1994.

Atrium

Q: What is Atrium's official website and social media links?

Atrium's official website is atriumnyc.com. Atrium has social profiles on LinkedIn.

Q: How many employees does Atrium have currently?

Atrium has approximately 49 employees.

Q: What technology does Atrium use?

Atrium's tech stack includes OpenResty, Lua, Nginx, Google Cloud, GoDaddy.

Q: What is Atrium's NAICS code?

Atrium's NAICS code is 448 (Clothing and Clothing Accessories Stores).

Retail Apparel and FashionNew York, United States11-50 Employees

Since 1994, Atrium has been known for its extensive selection of fashion-forward merchandise and has become the ultimate destination for men’s and women’s style. With a 2,400 sq ft flagship in Manhattan, and locations in Brooklyn and Miami Beach, Atrium provides a personalized shopping experience that draws everyone from industry insiders and celebrities, to the everyday shopper.

The company’s mission is simple – to provide customers with today’s best fashion brands and tomorrow’s top trends. 

Manhattan: 644 Broadway, New York NY 10012 | 212-473-9200
Brooklyn: 233 Flatbush Ave, Brooklyn NY 11217 | 347-889-6114
Miami: 1931 Collins Ave, Miami Beach FL 33139 | 305-695-0757

www.atriumnyc.com